Alternative pathway of complement is activated during in vitro ventricular assist

Journal of Investigative Medicine

Volumn 47, Issue 9, 1999, Pages 502-506

  Chen, John C ^a,b   Huynh, Thanh N ^a   Serna, Dan L ^a   Sun, Chien P ^a   Ha, Hongphuc ^a   Steward, Earl ^a   Webster, Scott ^a   Brenner, Matthew ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alternative pathway; Classical pathway; Thromboembolism; Ventricular assist complement

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BIOLOGICAL MARKER; COMPLEMENT C4D; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ARTICLE; ASSISTED CIRCULATION; BLOOD; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONGESTIVE HEART FAILURE; HEART ASSIST DEVICE; HUMAN; IN VITRO STUDY; METABOLISM;

ASSISTED CIRCULATION; BIOLOGICAL MARKERS; COMPLEMENT ACTIVATION; COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY; COMPLEMENT C3B; COMPLEMENT C4; COMPLEMENT C4B; COMPLEMENT PATHWAY, ALTERNATIVE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS;

EID: 0033228031     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994;13:S107-12.
2. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
3. United Network for Organ Sharing (UNOS). UNOS Update 1993;9:25.
4. Corry DC, Richenbacher WE. Mechanical circulatory support: past, present, and future. Surgical Rounds 1998;426-39.
5. Serna DL, King BO, Huh J, Jalal R, Tran L, Chen JC. Evidence for selective degradation of platelet GP IIb/IIIa complex after prolonged in vitro ventricular assist. J Investig Med 1998;46:279-83.
6. Chen JC, Serna DL, Tran LM, Huh J, Powell LL, King BO, Jalal R, Steward E, Newman RS. Protection of platelet glycoprotein IIb/IIIa receptor complex preserves platelet function during in vitro ventricular assisted circulation. ASAIO J 1998;44:M682-4.
7. Serna DL, Huh J, Ha H, Parhizgar SS, Chen JC. Platelet glycoprotein IIb/IIIa inhibitor attenuates complement activation during in vitro ventricular assist circulation. ASAIO J 1998;44:M352-5.
8. Schmaier AH, Smith PM, Colman RW. Platelet C1 inhibitor, a secreted alpha-granule protein. J Clin Invest 1985;75:242-50.
9. Polley MJ, Nachman RL. Human platelet activation by C3a and C3a des-arg. J Exp Med 1983;158:603-15.
10. Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacob HS. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. J Clin Invest 1978;61:1161-7.
11. Wilhelm CR, Ristich J, Kormos RL, Wagner WR. Monocyte tissue factor expression and ongoing complement generation in ventricular assist device patients. Ann Thorac Surg 1998;65:1071-6.
12. Downing SW, Edmunds LH Jr. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992;54:1236-43.
13. Kolb WP, Morrow PR, Tamerius JD. Ba and Bb fragments of Factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples. Complement and Inflammation 1989;6:175-204.
14. Chenoweth DE. Complement activation in extracorporeal circuits. Ann NY Acad Sci 1987;516:306-15.
15. Kerr MA. The human complement system: assembly of the classical pathway C3 convertase. Biochem J 1980;189:173-81.
16. Medof ME, Nussenzweig V. Control of the function of substratebound C4b-C3b by the complement receptor Cr1. J Exp Med 1984;159:1669-85.
17. Peerschke EI, Ghebrehiwet B. C1q augments platelet activation in response to aggregated Ig. J Immunol 1997;159:5594-8.
18. Peerschke EI, Reid KB, Ghebrehiwet B. Platelet activation by C1q results in the induction of αIIb/β3 integrins (GP IIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med 1993;178:579-87.
19. Livingston ER, Fisher CA, Bibidakis EJ, Pathak AS, Todd BA, Furukawa S, McClurken JB, Addonizio VP, Jeevanandam V. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation 1996;94:II227-34.
20. Gyongyossy-Issa M, McLeod E, Devine DV. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets. J Lab Clin Med 1994;123:859-68.
21. Van der Graff F, Koedam JA, Bouma BN. Inactivation of kallikrein in human plasma. J Clin Invest 1983;71:149-59.
22. Laurell AB, Johnson U, Martensson U, Sjoholm AG. Formation of complexes composed of C1r, C1s, and C1 inactivator in human serum on activation of C1. Acta Pathol Microbiol Scand 1978;86:299-306.